• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. MYOSURE XL HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. MYOSURE XL HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Model Number 50-501XL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 11/14/2018
Event Type  Death  
Manufacturer Narrative
Lot and serial number of the disposable device not provided by the complainant; therefore, the expiration date is not known.The device is not being returned; therefore, a failure analysis of the complaint device cannot be completed.Lot number of the disposable device not provided by the complainant; therefore, the manufacture date is not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.Internal complaint reference: (b)(4).
 
Event Description
It was reported that on (b)(6) 2018 a myosure tissue removal procedure with aquilex fluid management was performed.Prior to the myomectomy the physician performed a laparoscopic salpingectomy.According to the clinical account manager, "there was fluid on the floor so the gyn coordinator did a manual count which was 2100cc." "the procedure went along as normal and upon leaving the patient's vital signs were all normal." the clinical account manager received a call on (b)(6) 2018 from the gyn coordinator to report that the patient was found unresponsive at home on (b)(6) 2018 and was transported to the emergency room and subsequently expired.The presumptive diagnosis was pulmonary embolism which was ultimately confirmed on autopsy.Additional information received on (b)(6) 2018 reported that the patient was unable to have a bowel movement for 5 days post operatively and called the physician.She spoke with a partner of the physician and was advised to use a suppository.The autopsy report determined multiple pulmonary emboli in the chest.Based on follow-up the medical director's judgement is that the myosure xl and aquilex systems did not cause or contribute to a serious injury nor does the information indicate a malfunction of either device that would be likely to cause or contribute to this event.Pelvic surgery of any type can lead to pe but the risk of pe is not directly related to the device(s) used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE XL HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
Manufacturer Contact
sidra piracha
250 campus drive
marlborough, MA 01752
5082638884
MDR Report Key8180959
MDR Text Key130898277
Report Number1222780-2018-00257
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K122498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial
Report Date 11/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model Number50-501XL
Device Catalogue Number50-501XL
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/20/2018
Initial Date FDA Received12/19/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MYOSURE CONTROL UNIT: SN UNKNOWN
Patient Outcome(s) Death;
Patient Age41 YR
-
-